- Home
- RMCO vs SCNX Comparison
RMCO vs SCNX Comparison
Compare RMCO & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCO
- SCNX
- Stock Information
- Founded
- RMCO 2021
- SCNX 2010
- Country
- RMCO United States
- SCNX United States
- Employees
- RMCO N/A
- SCNX N/A
- Industry
- RMCO Multi-Sector Companies
- SCNX Other Pharmaceuticals
- Sector
- RMCO Miscellaneous
- SCNX Health Care
- Exchange
- RMCO Nasdaq
- SCNX Nasdaq
- Market Cap
- RMCO 45.7M
- SCNX 21.2M
- IPO Year
- RMCO N/A
- SCNX 2020
- Fundamental
- Price
- RMCO $3.10
- SCNX $0.53
- Analyst Decision
- RMCO Buy
- SCNX
- Analyst Count
- RMCO 1
- SCNX 0
- Target Price
- RMCO N/A
- SCNX N/A
- AVG Volume (30 Days)
- RMCO 162.9K
- SCNX 6.0M
- Earning Date
- RMCO 11-14-2025
- SCNX 11-05-2025
- Dividend Yield
- RMCO 0.33%
- SCNX N/A
- EPS Growth
- RMCO N/A
- SCNX N/A
- EPS
- RMCO N/A
- SCNX N/A
- Revenue
- RMCO $2,641,171.00
- SCNX $128,202.00
- Revenue This Year
- RMCO N/A
- SCNX N/A
- Revenue Next Year
- RMCO N/A
- SCNX N/A
- P/E Ratio
- RMCO N/A
- SCNX N/A
- Revenue Growth
- RMCO 292.46
- SCNX N/A
- 52 Week Low
- RMCO $0.90
- SCNX $0.46
- 52 Week High
- RMCO $4.76
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- RMCO 52.98
- SCNX 22.65
- Support Level
- RMCO $2.84
- SCNX $0.67
- Resistance Level
- RMCO $4.29
- SCNX $0.57
- Average True Range (ATR)
- RMCO 0.53
- SCNX 0.09
- MACD
- RMCO 0.02
- SCNX -0.01
- Stochastic Oscillator
- RMCO 31.91
- SCNX 9.26
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.